69 - The Scottish Inflammatory Prognostic Score (SIPS) identifies poor responders to first-line chemoimmunotherapy in non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: 69 - The Scottish Inflammatory Prognostic Score (SIPS) identifies poor responders to first-line chemoimmunotherapy in non-small cell lung cancer.
Authors: Raynes, George (AUTHOR), Price, Gareth (AUTHOR), Yan, Xiangfei (AUTHOR), Barrie, Colin (AUTHOR), Maclennan, Kirsty (AUTHOR), Campbell, Sorcha (AUTHOR), Evans, Tamasin (AUTHOR), Tufail, Aisha (AUTHOR), Harrow, Stephen (AUTHOR), MacKean, Melanie (AUTHOR), Philips, Iain (AUTHOR), Stares, Mark (AUTHOR)
Source: Lung Cancer (01695002). 2022 Supplement 1, Vol. 165, pS33-S34. 2p.
Database: Academic Search Ultimate
Description
ISSN:01695002
DOI:10.1016/S0169-5002(22)00116-7